Frank Torti, président et président du conseil Vant, a vendu le 19 février 2026 un total de 3 000 000 d'actions de Roivant Sciences pour un montant de 82 039 460 $. Suite au dépôt ...
L’action de Roivant Sciences Ltd a atteint un sommet historique de 27,95$, marquant une étape importante pour cette société biopharmaceutique. L’action se négocie à seulement 1% en dessous de son plus ...
The average one-year price target for Roivant Sciences (NasdaqGS:ROIV) has been revised to $32.44 / share. This is an ...
“With the brepocitinib CS program now moving into Phase 3 alongside the dermatomyositis and non-infectious uveitis programs, Priovant continues to advance our goal of developing brepocitinib as a ...
WASHINGTON, DC – When billionaires are in the spotlight for their oversized influence in Washington, especially in the Trump administration, comes this news: Vivek Ramaswamy’s wealth has soared even ...
Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced the appointment of Maykin Ho, Ph.D., to its board of directors, and the promotions of Nathan ...
Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results